QRL Bioscience
QRL Bioscience is a science and technology-driven organization committed to solving problems related to chronic degenerative diseases, especially non-healing wounds such as diabetic foot ulcers, venous leg ulcers, and skin ulcers. They develop novel cell-based therapies and have manufacturing capacities for cell therapy and cell biology products, aiming to promote wound healing and tissue regeneration.
Industries
Nr. of Employees
small (1-50)
QRL Bioscience
Plot No. E7+E8/13, First Floor, GIDC Electronic Estate, Sector 26, Gandhinagar - 382023
Products
Autologous live cell therapy for chronic non-healing wounds
An autologous, live cell–based therapeutic developed to promote healing in chronic non‑healing wounds such as diabetic foot ulcers, venous leg ulcers and other skin ulcers.
Regenerative bio-therapeutic candidate for myocardial infarction
A bio-therapeutic program under development aimed at regenerating damaged heart muscle after myocardial infarction.
Autologous live cell therapy for chronic non-healing wounds
An autologous, live cell–based therapeutic developed to promote healing in chronic non‑healing wounds such as diabetic foot ulcers, venous leg ulcers and other skin ulcers.
Regenerative bio-therapeutic candidate for myocardial infarction
A bio-therapeutic program under development aimed at regenerating damaged heart muscle after myocardial infarction.
Services
Manufacturing capacity for cell therapy and cell biology–based products to support preclinical, clinical and commercial needs.
Production of cell-based products for clients covering preclinical, clinical and commercialization stages.
Characterization of cellular populations by immunophenotyping using flow cytometry platforms.
Assessment of cytotoxicity of compounds or products in primary cells and cell lines.
GMP-based processing of blood to produce customized, highly concentrated PRP formulations enriched for growth factors for tissue repair.
Manufacturing capacity for cell therapy and cell biology–based products to support preclinical, clinical and commercial needs.
Production of cell-based products for clients covering preclinical, clinical and commercialization stages.
Characterization of cellular populations by immunophenotyping using flow cytometry platforms.
Assessment of cytotoxicity of compounds or products in primary cells and cell lines.
GMP-based processing of blood to produce customized, highly concentrated PRP formulations enriched for growth factors for tissue repair.
Expertise Areas
- Cell therapy manufacturing (CMC)
- GMP-compliant cell processing
- Preclinical development of cell-based therapeutics
- Regenerative medicine for chronic wounds and cardiac repair
Key Technologies
- Flow cytometry (immunophenotyping)
- GMP cell processing and cleanroom manufacturing
- Autologous cell therapy methods
- In vitro cytotoxicity assays
News & Updates
An article discussing the challenges of chronic leg ulcers in India.
An article about the indications of immunotherapy.
An article about the indications of cell therapy.
An article discussing the challenges of chronic leg ulcers in India.
An article about the indications of immunotherapy.
An article about the indications of cell therapy.